The mds Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the mds Hub cannot guarantee the accuracy of translated content. The mds and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View mds content recommended for you
Theo de WitteWorld-leading experts in MDS shared the top abstracts from the EHA2021 Virtual Congress that they believed could have the greatest impact on clinical practice.
Did you miss EHA2021? In this downloadable resource, we present comments from the MDS Hub Executive Steering Committee Chair Theo de Witte on studies investigating novel agents, as well as new ways to look at myelodysplastic immune compositions.
EHA2021 | Practice-changing abstracts in myelodysplastic syndromes
Did you miss EHA2021? Download the resource below to view our Executive Steering Committee Chair’s selection of practice-changing abstracts in MDS.
Highlights of EHA 2021
Please indicate your level of agreement with the following statements:
The content was clear and easy to understand
The content addressed the learning objectives
The content was relevant to my practice
I will change my clinical practice as a result of this content